Profil
Suhail Nurbhai has been Vice President of Clinical Development for Dynogen Pharmaceuticals, Inc. since June 2005.
Prior to joining Dynogen Pharmaceuticals, he was an Executive Director and Head of CNS Clinical Research and Development for Pfizer, Inc. from 1993 to 2005.
Previously, Dr. Nurbhai worked for the Gastroenterology Department of Broad Green Hospital.
He was a Member of the Royal College of Physicians for the United Kingdom.
Dr. Nurbhai received a degree in Medicine from Dundee University in Scotland and a Master degree in General Medical Training from the University of Manchester.
Ehemalige bekannte Positionen von Suhail Nurbhai
| Unternehmen | Position | Ende |
|---|---|---|
Dynogen Pharmaceuticals, Inc.
 Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | Corporate Officer/Principal | 13.11.2009 |
| PFIZER, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
Ausbildung von Suhail Nurbhai
| University Of Dundee | Graduate Degree |
| The University of Manchester | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | Health Technology |
